CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-01 | Mack David Henry President and CEO | Sale | −58,411 | $1.06 | $62K | 536,133 |
| 2021-07-21 | Mack David Henry President and CEO | Sale | −26,767 | $35.76 | $957K | 12,470 |
| 2021-07-20 | Mack David Henry President and CEO | Sale | −1,029 | $35.53 | $37K | 12,470 |
| 2021-06-28 | Mack David Henry President and CEO | Sale | −204 | $35.53 | $7K | 12,470 |
| 2021-05-21 | Mack David Henry President and CEO | Sale | −6,207 | $35.71 | $222K | 2,470 |
| 2021-05-20 | Mack David Henry President and CEO | Sale | −7,793 | $35.60 | $277K | 2,470 |
Page 1 of 1 · 6 trades